| Longitudinal regret after treatment for low‐and intermediate‐risk prostate cancer LM Hurwitz, J Cullen, DJ Kim, S Elsamanoudi, J Hudak, M Colston, ... Cancer 123 (21), 4252-4258, 2017 | 64 | 2017 |
| A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic LM Hurwitz, J Cullen, S Elsamanoudi, DJ Kim, J Hudak, M Colston, ... Urologic Oncology: Seminars and Original Investigations 34 (5), 233. e17-233 …, 2016 | 47 | 2016 |
| A urine exosome gene expression panel distinguishes between indolent and aggressive prostate cancers at biopsy I Kohaar, Y Chen, S Banerjee, T Borbiev, HC Kuo, A Ali, L Ravindranath, ... The Journal of urology 205 (2), 420-425, 2021 | 38 | 2021 |
| Quality of life and needs assessment on people living with HIV and AIDS in Malawi APC Fan, HCC Kuo, DYT Kao, DE Morisky, YMA Chen AIDS care 23 (3), 287-302, 2011 | 36 | 2011 |
| Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer KH Hammerich, TF Donahue, IL Rosner, J Cullen, HC Kuo, L Hurwitz, ... Urologic Oncology: Seminars and Original Investigations 35 (7), 460. e21-460 …, 2017 | 27 | 2017 |
| Predicting prostate cancer progression as a function of ETS-related gene status, race, and obesity in a longitudinal patient cohort J Cullen, D Young, Y Chen, M Degon, J Farrell, J Sedarsky, W Baptiste, ... European urology focus 4 (6), 818-824, 2018 | 20 | 2018 |
| Prognostic features of Annexin A2 expression in prostate cancer SH Tan, D Young, Y Chen, HC Kuo, A Srinivasan, A Dobi, G Petrovics, ... Pathology 53 (2), 205-213, 2021 | 19 | 2021 |
| The 17-gene genomic prostate score test as a predictor of outcomes in men with unfavorable intermediate risk prostate cancer J Cullen, HC Kuo, J Shan, R Lu, T Aboushwareb, SK Van Den Eeden Urology 143, 103-111, 2020 | 18 | 2020 |
| Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate … S Sharad, ZM Sztupinszki, Y Chen, C Kuo, L Ravindranath, Z Szallasi, ... Cancers 11 (12), 1995, 2019 | 17 | 2019 |
| Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression W Gesztes, C Schafer, D Young, J Fox, J Jiang, Y Chen, HC Kuo, ... Scientific reports 12 (1), 5404, 2022 | 16 | 2022 |
| TaqMan Array Card testing of participant-collected stool smears to determine the pathogen-specific epidemiology of travellers’ diarrhoea MD Tisdale, DR Tribble, I Mitra, K Telu, HC Kuo, JA Fraser, J Liu, ... Journal of Travel Medicine 29 (1), taab138, 2022 | 15 | 2022 |
| Race, tumor location, and disease progression among low‐risk prostate cancer patients JG Mygatt, J Cullen, SA Streicher, HC Kuo, Y Chen, D Young, W Gesztes, ... Cancer medicine 9 (6), 2235-2242, 2020 | 13 | 2020 |
| Impact of age and race on health-related quality of life outcomes in patients undergoing radical prostatectomy for localized prostate cancer N Posielski, J Frankel, HC Kuo, O Ho, S Elsamanoudi, D Nousome, ... Urology 163, 99-106, 2022 | 6 | 2022 |
| Alkaline phosphatase kinetics predict metastasis among prostate cancer patients who experience relapse following radical prostatectomy CA Salter, J Cullen, C Kuo, Y Chen, L Hurwitz, AR Metwalli, J Dimitrakoff, ... BioMed research international 2018 (1), 4727089, 2018 | 5 | 2018 |
| In-school study of prevalence of fetal alcohol spectrum disorder in east Taiwan HT Kuo, HP Wu, Q Li, FC Zhou, DE Morisky, ML Lee ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 36, 280A-280A, 2012 | 5 | 2012 |
| Race‐specific prostate cancer outcomes in a cohort of low and favorable‐intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017 SP Stroup, AH Robertson, KC Onofaro, MG Santomauro, NR Rocco, ... Cancer medicine 11 (24), 4756-4766, 2022 | 4 | 2022 |
| Prospective quality of life in men choosing open vs. robotic radical prostatectomy: long-term results from a racially diverse multi-institutional database E Kord, N Jung, B Boehm, G Conti, HC Kuo, J Frankel, J Flores, K Levie, ... World journal of urology 40 (6), 1427-1436, 2022 | 4 | 2022 |
| Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men A Duncan, D Nousome, R Ricks, HC Kuo, L Ravindranath, A Dobi, ... Biomedicines 11 (5), 1404, 2023 | 3 | 2023 |
| Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017 N Oehrlein, SA Streicher, HC Kuo, A Chaurasia, J McFadden, D Nousome, ... Cancer medicine 11 (22), 4354-4365, 2022 | 3 | 2022 |
| Use and predictors of expectant management of low and intermediate risk localized prostate cancer in elderly men HT Tsai, G Philips, KL Taylor, K Kowalczyk, HC Kuo, AL Potosky Urology practice 4 (2), 132-139, 2017 | 3 | 2017 |
